Page last updated: 2024-08-26

beta-hydroxyisovalerylshikonin and fluorouracil

beta-hydroxyisovalerylshikonin has been researched along with fluorouracil in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Li, SS; Liu, X; Rao, Z; Yi, J; Zhou, W1
Gong, XF; Horie, M; Itabe, H; Kajimoto, S; Manabe, H; Masuda, Y; Nakajo, S; Nakaya, K; Obama, T; Shibayama-Imazu, T1
Asahina, Y; Hashiba, T; Hayashi, T; Honda, M; Kaneko, S; Nio, K; Nishitani, M; Okada, H; Suda, T; Sugimoto, S; Takatori, H; Yamashita, T1

Other Studies

3 other study(ies) available for beta-hydroxyisovalerylshikonin and fluorouracil

ArticleYear
Synthesis and antitumour activity of β-hydroxyisovalerylshikonin analogues.
    European journal of medicinal chemistry, 2011, Volume: 46, Issue:9

    Topics: Antineoplastic Agents; Cell Line, Tumor; Chromatography, High Pressure Liquid; Humans; Mass Spectrometry; Naphthoquinones; Structure-Activity Relationship

2011
A tyrosine kinase inhibitor, beta-hydroxyisovalerylshikonin, induced apoptosis in human lung cancer DMS114 cells through reduction of dUTP nucleotidohydrolase activity.
    Biochimica et biophysica acta, 2008, Volume: 1782, Issue:1

    Topics: Amino Acid Sequence; Antineoplastic Agents; Antioxidants; Apoptosis; Cell Line, Tumor; Cell Proliferation; Deoxyuracil Nucleotides; Enzyme Activation; Fluorouracil; Humans; Lung Neoplasms; Molecular Sequence Data; Naphthoquinones; Phosphoproteins; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrophosphatases; RNA, Small Interfering

2008
Beta-Hydroxyisovaleryl-Shikonin Eradicates Epithelial Cell Adhesion Molecule-Positive Liver Cancer Stem Cells by Suppressing dUTP Pyrophosphatase Expression.
    International journal of molecular sciences, 2023, Nov-14, Volume: 24, Issue:22

    Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Epithelial Cell Adhesion Molecule; Fluorouracil; Humans; Liver Neoplasms; Neoplastic Stem Cells

2023